BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03709706-completion@plaintrial.com
DTSTAMP:20261028T203325Z
DTSTART;VALUE=DATE:20221104
SUMMARY:Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel\, 
 GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ES
 O-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either 
 Alone or in Combination With Pembrolizumab — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03709706
URL:https://plaintrial.com/trial/NCT03709706
END:VEVENT
END:VCALENDAR